Brightwake Ltd (KTP#2)

Brightwake Ltd (KTP#2)

Brightwake Ltd are working in partnership with the University of Strathclyde, Department of Biomedical Engineering on a 24 month KTP to develop a novel medical device for use in the intensive care treatment of patients with sepsis.  The technology will have the dual function of removing and exchanging plasma while also removing cytokines from the resultant blood product prior to reinfusion.

Read More...